Medical Therapy of Ulcerative Colitis 2014
DOI: 10.1007/978-1-4939-1677-1_1
|View full text |Cite
|
Sign up to set email alerts
|

The History of Medical Therapy of Ulcerative Colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 152 publications
0
2
0
Order By: Relevance
“…While probiotics can bene t the intestinal tract, which related to host health. Probiotics prevent some bacteria pathogens from reaching the colonic lamina propria through competitive inhibition, and stimulate the mucosal immune system at the same time (Mudireddy et al, 2014). Kai et al (2017) reported that L. plantarum administration could relieve the duodenal in ammation of mice with enteritis (Kai et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…While probiotics can bene t the intestinal tract, which related to host health. Probiotics prevent some bacteria pathogens from reaching the colonic lamina propria through competitive inhibition, and stimulate the mucosal immune system at the same time (Mudireddy et al, 2014). Kai et al (2017) reported that L. plantarum administration could relieve the duodenal in ammation of mice with enteritis (Kai et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Patients with ulcerative colitis often require daily multigram doses of 5-ASA to achieve therapeutic concentrations in the colon, 4 so it is desirable to minimize the amount of excipients or adjuvant molecules in the dosage form. Among approved prodrugs of 5-ASA, olsalazine is the most efficient by weight, since it is a homodimer of two 5-ASA molecules, whereas sulfasalazine and balsalazide are heterodimers of 5-ASA and carrier molecules.…”
mentioning
confidence: 99%